Market Highlights
Global COVID-19 Diagnostics Market is expected to register a CAGR of 6.28% during the forecast period, with a market value of USD 96,293.9 Million by 2027. COVID-19 is one of the most harmful infectious diseases that is caused by a coronavirus. Wuhan, China was the first place to experience the disease’s outbreak, followed by Europe, and then to the other countries globally by infected people. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/9710 Segment Analysis Global COVID-19 Diagnostics Market has been segmented by Type, Technology, and End Users. The market, based on type, has been bifurcated into molecular tests and serology tests. On the basis of technology, the market has been bifurcated into RT-PCR, isothermal amplification, CRISPR, ELISA, hybridization, and others. Based on End User, the COVID-19 diagnostics market has been segregated into hospitals, public health labs, private or commercial labs, and others. Regional Analysis Global COVID-19 Diagnostics Market, based on region, has been divided into the Europe, Americas, Asia-Pacific, and the Middle East & Africa. The Europe is likely to dominate the global COVID-19 diagnostics market. This can be attributed to the high COVID-19 morbidity and mortality observed among residents in long-term care facilities (LTCF) in European Union (EU) and European Economic Area (EEA) pose a major challenge for disease prevention and control in such settings, which raises the demand for the wide availability of diagnostics for immediate detection of COVID-19 cases. According to European Centre for Disease Control and Prevention, 157 312 deaths in the EU/EEA and the UK as of 19 May 2020 were reported. Moreover, the support from public & private organizations in tackling COVID-19 is also expected to drive market growth in the region. The American market for COVID-19 diagnostics is expected to be the second largest during the forecast period. Rising product launches by major players and ongoing public and private organizations’ efforts to control the spread of the virus is anticipated to drive the market growth. For instance, in March 2020, the US FDA issued a EUA for a molecular point of care test kit by Abbott for the rapid detection of COVID-19. Furthermore, the increasing numbers of corona virus-positive cases also act as a driving factor and support market growth. Asia-Pacific is estimated to be the fastest-growing market. With an increasing number of cases, governments across the Asia-Pacific countries are exploring the opportunities of allowing private laboratories to ramp up testing, which is boosting the market growth. For instance, In India, the Indian Council of Medical Research (ICMR) has approved 51 private laboratories for COVID-19 testing on March 31, 2020. Moreover, the increasing number of COVID-19 cases is also driving the market growth. The market in the Middle East & Africa is expected to witness steady growth. Countries such as Kuwait, the UAE, and Saudi Arabia are likely to show steady growth due to increasing COVID-19 cases and rising initiatives by governments to improve patient care. Key Players MRFR recognizes the following companies as the Key Players in the Global COVID-19 Diagnostics Market— Becton, Dickinson & Company (US), Bio-Rad Laboratories (US), Danaher Corporation (US), Abbott (US), F. Hoffmann-La Roche Ltd (Switzerland), Biomerieux SA (France), Genmark Diagnostics (US), Thermo Fisher Scientific (US), Qiagen (Germany), and Siemens AG (Germany). Browse Full Report Details @ https://www.marketresearchfuture.com/reports/covid-19-diagnostics-market-9710
0 Comments
Global Healthcare Personal Protection Equipment Market is expected to cross USD 10.116 Billion by 2027 at a CAGR of 9.17%.
Market Synopsis Personal Protective Equipment (PPEs) are protective gear designed to safeguard the health of workers by minimizing the exposure to a biological agent. It is one of the necessary tools in preventing transmission of infectious diseases not only in treatment centers but also in various activities, e.g. cleaning, waste management and safe burials, and community care related to the outbreak. Components of PPE are goggles, face-shield, mask, gloves, coverall/gowns (with or without aprons), head cover, shoe cover, and others. Impact of Covid-19 Outbreak on Healthcare Personal Protection Equipment Market Healthcare Personal Protection Equipment (PPE) are protective gears that are designed to safeguard the workers by minimizing the exposure to a biological agent. PPE helps healthcare workers to fight against novel coronavirus (COVID-19). The World Health Organization (WHO) has recommended several governments worldwide to increase the production of masks, gloves, respirators, and coveralls/gowns. It also recommended that PPE manufacturers must increase their production by 40% and prioritizing their orders to countries with a high demand-supply gap. Several countries, including India, have considered importing PPE kits to meet its requirements from China, Singapore, and South Korea. Although a tender was rolled out last week by the government’s nodal procurement agency HLL Lifecare, the government has chosen not to wait for the bids to be released, rather than source it from other countries. As of the 3rd week of April, the coronavirus (COVID-19) pandemic crossed two million cases globally. The increasing demand for hand protection, respiratory protection, and protective clothing in the healthcare industry to ensure people’s safety during the ongoing COVID-19 pandemic is expected to boost the demand for PPE. Furthermore, the increasing government initiatives to facilitate the import of PPE is expected to drive the market growth. For instance, in March 2020, in response to the COVID-19 outbreak, the Food and Drug Administration (FDA) initiated numerous steps to improve the US stocks of PPE. A few of its measures include adjustments in import screening, flexibility to manufacturers, and creation of special mailbox service, among other provisions. We have observed the massive impact of novel coronavirus on people’s lives over the last five months. It has also impacted various industries across the globe, eventually affecting the global economy. Some industries have experienced negative growth, whereas some industries have experienced tremendous demand and have generated massive revenues in this period. Covid 19 Impact on Healthcare Personal Protection Equipment market is the one of the positive impact sector on global industry Healthcare Personal Protection Equipment Market Influencer PPE helps healthcare workers to fight against novel coronavirus (COVID-19). The World Health Organization (WHO) has recommended the governments across the world to increase the production of masks, gloves, respirators, and coveralls/gowns. It also recommended that PPE manufacturers must increase their production by 40% and prioritizing their orders to the countries with a high demand-supply gap. Market Drivers
By Product
By Region
Global Particle Counter Market Solid Segment Analyzed By Latest Trends, Growth Rate And 2025 Insight12/31/2020 Market Highlights
According to MRFR analysis, the global particle counter market is expected to register a CAGR of ~7.1% during the forecast period of 2019 to 2025 and was valued at USD 89.23 million in 2018. A particle counter is a tool for monitoring indoor air quality to understand the concentration of particles in the air in cleanrooms and workplaces. This device would not identify specifically what kinds of dust particulates are present in the air, but it will identify how many airborne particles of a certain size are present in the environment. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8776 The growth of the global particle counter market is determined by numerous factors such as increasing incidence of chronic disorders, stringent regulatory scenario, and the adoption of particle counters to maintain air quality. However, the high cost of particle counters and technical limitations of particle counters is projected to restrain the growth of the market during the forecast period. The global particle counter market is currently dominated by several market players. The key players are involved in expansion, acquisition, and strategic collaborations to strengthen their market positions. Regional Analysis The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The market in the Americas region is anticipated to hold the largest market share owing to the high health care spending, well-developed technology, and growing geriatric population. Additionally, stringent protocol and guidelines by the FDA for the maintenance of the cleanroom environment are driving the market growth. The particle counter market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European particle counter market has been categorized into Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The Particle counter market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the presence of a huge patient population, rapid development in technology and the expansion of healthcare facilities, the market in Asia-Pacific is expected to be the fastest-growing during the forecast period. The particle counter market in the Middle East & Africa has been divided into the Middle East and Africa. Segmentation The global particle counter market has been segmented based on product type, modularity, technology, and end-user. The market, based on product type, has been divided into airborne particle counters and liquid particle counters. The airborne particle counters are likely to hold maximum market share in the global particle counter market due to the increasing use of these particle counters for cleanroom monitoring and the growing stringency of air pollution monitoring. The global particle counter market based on technology has been segregated into online particle counters and offline particle counters. The online particle counters segment is anticipated to hold the largest share in the market due to its ability to monitoring solutions in hydraulic and lubricating systems. The global particle counter market based on modularity has been segregated into portable particle counters, remote particle counters, and handheld particle counters. The portable particle counters segment is anticipated to hold the largest share as they are easy to carry and are designed to save time and money. The end-user segments of the market are the medical device industry, the pharmaceutical industry, research laboratories, and others. The medical device industry segment is expected to hold the largest share of the market, due to increased R&D expenditure and the establishment of new manufacturing facilities by global pharmaceutical giants in newer geographies. Key Players Some of the key players in the global particle counter market are Particle Measuring Systems, Inc. (A Spectris Company), Beckman Coulter (A Danaher Corporation Company), Rion Co., Ltd., Lighthouse Worldwide Solutions, Inc., TSI Incorporated, Climate Instruments Company, Setra Systems, Met One Instruments, Inc., and Chemtrac, Inc. Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/particle-counter-market-8776 Market Highlights
Global Whole Exome Sequencing Market is estimated to be valued at USD 2,696.03 Million by 2025 and is expected to register a CAGR of 19.80% during the forecast period. Whole exome sequencing is a widely used next-generation sequencing (NGS) method to determine the nucleotide sequence primarily of the protein-coding regions of an individuals related sequences, representing approximately 1% of the complete DNA sequence. The human exome represents less than 2% of the genome but contains ~85% of known disease-related variants, which makes it major usage in the identification and the determination of genetic variants causing various diseases such as Miller syndrome and Alzheimer’s. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8763 Segment Analysis The global whole exome sequencing market has been segmented on the basis of product, technology, application, and end user. The market, based on product, has been segmented into kits, sequencer, and services. Kits are further segmented into DNA Fragmentation, End Repair, A-Tailing, And Size Selection Kits, Library Preparation, and Target Enrichment. Services are further sub-segmented into Sequencing Services, Data Analysis (Bioinformatics), and Others. The global whole exome sequencing market, by technology, has been categorized as Sequencing by Synthesis (SBS), ION Semiconductor Sequencing, and others. The market by application is segmented into diagnostics, drug discovery and development, agriculture and animal research, others. Based on end user, the market is segmented into research centers and government institutes, hospitals and diagnostics centers, pharmaceutical & biotechnology companies, and others. Regional Analysis The Americas was the largest market for whole exome sequencing in 2019. The growth of the Americas market is due to the high prevalence rate of cancer and other chronic disorders and rising healthcare expenditure. Additionally, favorable initiatives by the government and other organizations for the development and adoption of whole-exome sequencing technologies are driving the market for whole-exome sequencing. For instance, in 2018, All of Us Research Program, a part of the National Institutes of Health, awarded funds over USD 28.6 million to establish three genome centers in the US. These centers aim to produce genome data for researchers and the program’s precision medicine research platform, a national resource to support studies on a variety of important health questions. Europe is the second-largest market for whole exome sequencing with Western Europe, holding the largest market share. The European market is expected to register a sturdy growth rate during the forecast period due to rising cases of cancer and increasing programs for the adoption of genome sequencing. According to the International Agency for Research on Cancer, in 2018, there were 4,229,662 cases of cancer in Europe. This increasing number of cases of cancer and rising genome mapping programs are expected to have a positive impact on the growth of the whole exome sequencing market. Asia-Pacific is expected to represent the highest market growth potential over the forecast period due to the growing patient pool and increasing technological advancements. The fast growth of the Asia-Pacific region is due to the increasing per capita income along with government initiatives to enhance the quality of healthcare and rising diabetes being the major concern in this region. China, India, and Australia have a lucrative market for whole exome sequencing due to the growing older population. Moreover, according to the report published by the United Nations in 2015, the number of older people aged 60 years or above in the world is predicted to grow by 56% between 2015 and 2030. 66% of the older population out of the total global population would also reside in the Asia-Pacific region. In the Middle East & Africa, the whole exome sequencing market is driven by increasing obesity issues, rising initiatives by governments to improve patient care, and favorable reimbursement policies. Key Players Market Research Future (MRFR) Illumina Inc. (US), BGI (China), Eurofins Scientific (Belgium), Thermo Fisher Scientific (US), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), GENEWIZ (US), Ambry Genetics (US ), Macrogen, Inc. (South Korea), Integragen SA (France), as the Key Players in the Global Whole Exome Sequencing Market. Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/whole-exome-sequencing-market-8763 Digital 3D Printing Market size is expected to register a CAGR of 20.54% to reach USD 5,214.8 Million by 2025. 3D Printing is a process in which physical objects are created by depositing materials in layers based on a digital model. The creation of a 3D printed object is achieved using additive processes. In an additive process, an object is created by laying down successive layers of materials until the object is created. 3D Printing enables to produce complex shapes using less material than traditional manufacturing methods. Each 3D Printing process requires software, hardware, and materials to work together.
Market Dynamics Increasing applications of Digital 3D Printing in healthcare industry is expected to boost market growth. 3D Printing techniques have empowered medical practitioners, manufacturers of medical devices, as well as researchers due to their use in dental & orthodontic treatments, orthopedic implants, tissue engineering, and drug development. As a result, the increasing benefits of the mentioned applications would boost digital 3d printing market growth. 3D Printing technique is useful to speed up procedures and helps to minimize the trauma faced by patients due to conventional treatment options. Technological advancements in digital 3D Printing, rising public-private funding for 3D Printing activities are the major drivers that contribute to the growth of the digital 3D Printing market. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8680 Segmentation Global Digital 3D Printing Market analysis is segmented based on Component, Material, Technology, Application and End User. The market, based on component, has been categorized as system/device and software/services. System/Device held 867.53 market value in 2018 Global digital 3D Printing market, based on material, has been segregated into polymers, metal & alloy, ceramics, and others. Global digital 3D Printing market trends based on technology, has been segregated into stereolithography, deposition modeling, laser sintering, jetting technology, electron beam melting, and others. Global digital 3D Printing market based on application has been categorized into dental, prosthetics, orthopedics, medical components, tissue engineering, hearing aids, drug screening, and others. Global digital 3D Printing market, based on end user, has been segregated into hospitals & surgical centers, dental clinics & laboratories (offices), pharmaceutical & biotechnology companies, and others. Regional Analysis Global Digital 3D Printing Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas led the market and accounted for the largest share in 2018, owing to the existence of medical device companies and the rising prevalence of diseases along with increased adoption of treatment by patients. In North America, the US held the largest of the market share in 2018 owing to the presence of major market players, developed healthcare infrastructure, high awareness, and availability of advanced treatment options. For instance, in November 2015, a group of medical researchers from North Carolina’s Wake Forest University developed a method to print the 3D form of custom medications in the configuration of pills. As a result, increasing applications of 3D Printing is expected to drive the market growth. Europe accounts for the second-largest share in the global digital 3D Printing market owing to the presence of favorable government initiatives & laws and target population base, rising prevalence of lifestyle-associated conditions, and the presence of developed economies such as Germany, the UK, and France. Since the ban on animal testing for cosmetics in 2013, the wellness industry had been a significant supporter of 3D Printing in Europe. Asia-Pacific is estimated to be the fastest-growing market during the forecast period due to the increasing per capita health spending, growing older population base, rising incidence of accidents, and developing the healthcare sector in China, Japan, India, and Australia. The Middle East & Africa digital 3D Printing market is segmented into two major regions, namely the Middle East and Africa. In this region, the Middle East is anticipated to dominate owing to the presence of countries such as Egypt, Saudi Arabia, and others. The Middle East and Africa has less economic developments and extremely low-income due to which the region accounts for the least market share but is expected to grow with the increasing cases of chronic diseases and demand for better treatments in countries. Key Players The Prominent Players in the Global Digital 3D Printing Market are Stratasys Ltd (US), 3D Systems, Inc. (US), Carbon, Inc. (US), EnvisionTEC (US), Formlabs (US), ExOne (US), Materialise (Europe), General Electric (US), Micron Dental (US), Renishaw PLC (UK). Some of the key strategies followed by players operating in the Global Digital 3D Printing Market were acquisitions, expansions, product launches, partnerships, mergers, collaborations, alliances, and product approvals.
Global Hyperspectral Imaging System Market held a value of USD 10,700 Million in 2018, at a CAGR of 17.4% during the assessment period of 2019 to 2025.
Hyperspectral Imaging System Market Synopsis Hyperspectral Imaging Systems (HIS) are also known as imaging spectroscopy. It was originated from remote sensing and has various applications in surveillance, remote sensing, machine vision/optical, and medical diagnostics. It can acquire 2D images across a wide range of the electromagnetic spectrum. Increasing applications for research in life sciences and the medical diagnostics sector in the past few years are responsible for a surge in demand for hyperspectral imaging systems. The key players involved in this market are actively focusing upon building partnerships, collaborations, and joint ventures with hospitals and ambulatory centers to strengthen their position in the market. Moreover, there is an increasing growth in various chronic diseases, which pushes the need for efficient hyperspectral imaging systems in the developing as well as underdeveloped regions. Hyperspectral Imaging System Market Influencer Rising funding and investments for the development of hyperspectral medical imaging systems are likely to provide favorable conditions for the growth of the hyperspectral medical imaging system market during the forecast period. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8741 Hyperspectral Imaging System Market Drivers
By Product
Market Scenario
The increasing prevalence of chronic diseases such as cancer, genetic diseases, and rare diseases, increase in adoption of genetic testing, rising company initiatives, technological advancements, need for efficient prenatal diagnosis, and increasing health awareness are estimated to drive the market during the forecast period. However, factors such as expensive tests, inaccuracy in results, and security concerns of the genes are estimated to restrain the market growth during the forecast period. Global Gene Panel Market size is expected to register a CAGR of 12.16% to reach USD 4,347.32 Million by 2025. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6100 Segmentation The global gene panel market is segmented on the basis of product and service, technique, design, application, and end-user. The gene panel market, by product and service, is segmented into test kits and testing services. The global gene panel market by technique is segmented into the amplicon-based approach and hybridization-based approach. The design segment is segmented into predesigned gene panels and customized gene panels. On the basis of application, the market is categorized into cancer risk assessment, pharmacogenetics, diagnosis of congenital disorders, and other applications. The cancer risk assessment segment is further sub-segmented into syndrome-specific gene panels, high-penetrance gene panels, high and moderate-penetrance gene panels, and comprehensive cancer risk panels. On the basis of end-user, the market is categorized into hospitals, diagnostic laboratories, research and academic institutes, and pharmaceutical and biotechnology companies. Key players Some of the key players for the global gene panel market are Thermo Fisher Scientific (US), F. Hoffmann-La Roche AG (Switzerland), Illumina, Inc., BGI (China), Agilent Technologies (US), Integrated DNA Technologies (IDT) (US), Eurofins Scientific (US), QIAGEN (Germany), GENEWIZ, Novogene Corporation (China), Personalis (US), GATC Biotech AG (GATC Biotech) (Germany), ArcherDx (US), GeneDx., CENTOGENE AG, and others. Regional Market Summary The Americas dominates the global market for gene panel. The increase in the patient pool for chronic diseases, government initiatives for the development of cancer treatment, and presence of strong market players such as Thermo Fisher Scientific drive the market growth in this region. Europe (the U.K., Belgium, France, and the Netherlands) is second in the market owing to the increasing research and development activities for cancer and congenital diseases. Also, the high occurrence rate of cancer in Europe influences the market growth in Europe. According to WHO, there are 3.7 million cases of cancer in Europe every year. Furthermore, Germany is predicted to dominate the European market as there were 2, 24,089 number of deaths due to cancer in 2014. Also, technological advancements coupled with an early diagnosis of cancer is likely to drive market growth for gene panel in Germany. Asia Pacific is expected to observe growth for the global gene panel market owing to the growing prevalence of cancer and increasing health expenditure. The Middle East and Africa with the presence of low-income countries, low healthcare expenditures, and stringent government regulations accounted for the least market share. Browse More Medical Device Reports @ https://www.marketresearchfuture.com/reports/gene-panel-market-6100 Facial Fat Transfer Market Shares Analysis, Key Development Strategies And Forecasts Till 202512/31/2020 Market Highlights
Facial Fat Transfer Market is estimated to be valued at USD 7789.1 Million by 2025 and is expected to register a CAGR of 11.05% during the forecast period. Facial fat transfer is a minimally invasive surgical procedure to move fat from an area of the body where it is plentiful and transfer it to the face to restore lost volume. The fat is gently removed using modern liposuction techniques and is then prepared for injecting into the face. Several dermal fillers are available in the market, designed to improve different parts of the face. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1780 Segment Analysis The Global Facial Fat Transfer Market has been segmented based on the target area, Treatment, End-User, and Region. Based on the target area, the market has been divided into naso-labial folds, lips, marionette folds, temples, chin, and under-eye area. Based on treatment, the market is further sub-segmented as dermal fillers, fat injections, and others. On the basis of end user, the market has been divided into hospitals, cosmetic surgery clinics, and others. Regional Analysis Geographically, the Global Facial Fat Transfer Market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. As per MRFR analysis, Americas were the largest market for facial fat transfer in 2018 and is expected to remain dominant during the review period. Increasing awareness regarding body aesthetics and the introduction of advanced technology in the facial rejuvenation industry are major factors that drive the growth of the facial fat transfer market in the American region. Europe accounted for a significant market share and is projected to be the second-largest market during the forecast period. The increasing demand for minimally invasive cosmetic procedures is fueling the facial fat transfer market growth in European countries. For instance, according to the British Association of Aesthetic Plastic Surgeons, in London, 2019, over 28,000 cosmetic procedures took place in 2018. The market in Asia-Pacific is expected to register a significant growth rate during the forecast period. The majority of the companies in Asia-Pacific are committed to investing in research and development of facial fat transfer treatments, which will ultimately boost the growth of the market. The growth of the Middle East and Africa facial fat transfer market is majorly attributed to developing healthcare infrastructure, and continuously increasing demand for facial fat transfer products. Africa holds the least share of the market due to the limited availability of funds and medical facilities Market Players Market Research Future (MRFR) recognizes DR. Korman (Israel), Galderma Laboratories, L.P. (US), Integra LifeSciences Corporation (Israel), Merz Pharma (Germany), Allergan (Ireland), SciVision Biotech Inc (Taiwan), Suneva Medical, Inc (US), Bausch Health Companies Inc (Canada), Teoxane Laboratories (Switzerland), Ipsen Pharma (France), Sinclair Pharma (UK) as the key players in the Global Facial Fat Transfer Market. Key Findings of the Study:
Market Highlights
Thoracolumbar Spine Devices Market is expected to register a CAGR of3.72% during the forecast period, with a market value of USD 8,484.7 Million till 2025. The human spinal cord, based on anatomy, is divided into three sections, namely cervical, thoracic, and lumbar. The cervical section is located at the beginning of the skull comprising of the first seven vertebrae. The thoracic spine is the midback consisting of the next 12 vertebrae, and the section from ribs to sacrum comprises the lumbar section consisting of the five lower vertebrae. The increasing obese population, high prevalence of spinal cord injuries (SCI), and increasing geriatric population are expected to enhance the market growth. However, the stringent regulatory policies, lack of awareness for the use of advanced technologies, and product recalls are projected to curb the growth of the market. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5657 Segment Analysis The global thoracolumbar spine devices market, by product type, has been segmented into spinal implants, devices and instrumentation, and spine biologics. Based on type of surgery, the Thoracolumbar spine devices market has been categorized as open surgery and minimally invasive surgery (MIS). The by material segment is further segmented as titanium, stainless steel, biomaterials, and others. Based on end user, the thoracolumbar spine devices market has been categorized as hospitals and clinics, ambulatory surgery centers, academic institutes and research centers, and others. Regional Analysis The Global Thoracolumbar Spine Devices Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The existence of medical device companies, developed healthcare infrastructure, significant per capita healthcare spending, high funding for research & development projects, focused researches in spine disorders along with grants from government healthcare agencies, and high adoption of advanced medical technologies in the US and Canada are likely to support the dominance of the Americas during the forecast period. Europe is anticipated to account for the second-largest market share during the forecast period. The market growth in Europe can be attributed to factors such as the increasing number of individuals affected by spinal cord injuries. For instance, according to the Association for Spinal Injury Research, Rehabilitation, and Reintegration, the number of people diagnosed with a spinal cord injury in the UK is 2500 per year. Asia-Pacific is likely to be the fastest-growing region in the global thoracolumbar spine devices market. The growing geriatric population and booming medical tourism sector in India, China, Australia, and Malaysia are likely to impact the regional market growth during the forecast period. According to the United Nations Department of Economic and Social Affairs (UN DESA), in 2017, 12% of the population in Asia and 17% in Oceania was aged 60 or above, which is projected to increase to 24% and 23%, respectively by 2050. This elderly population is more prone to develop thoracolumbar spine disorders, which are fostering market growth. India held a share of 16.2% in the Asia-Pacific thoracolumbar spine devices market in 2018. The Middle East & Africa market is projected to show gradual growth during the forecast period. In this region, the Middle East is anticipated to dominate owing to factors like increasing growth in the medical tourism sector. For instance, according to the Dubai Health Authority (DHA), in 2016, the medical tourism sector showed a significant growth of 9% to 10%, and more than 326,649 patients from all over the world visited Dubai for medical treatments. Market Players MRFR recognizes the following companies as the Key Players in the Global Thoracolumbar Spine Devices Market--Orthofix Holdings, Inc. (US), Alphatech holdings, Inc. (US), B. Braun Melsungen AG (Germany), Depuy Synthes (US), Exactech, Inc. (US), Globus Medical, Inc. (US), Medtronic Plc (Ireland), NuVasive, Inc. (US), ZIMMER BIOMET HOLDINGS, INC. (US), and STRYKER CORPORATION (US). Key Findings of the Study ·The Global Thoracolumbar Spine Devices Market was valued at USD 6,531.2 million in 2018 and is estimated to grow to USD 8,484.7 Million by 2025 at a CAGR of 3.72% during the assessment period ·The Americas accounted for the largest share of the global market due to the presence of key market players, sophisticated healthcare infrastructure, and increasing R&D in the field of thoracolumbar spine devices. ·Based on product type, the spine biologics segment accounted for a market share of 23.5% in 2018 ·On the basis of the end user, the hospitals and clinics segment dominated the market and accounted for a share of 48.7% in 2018 FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/thoracolumbar-spine-devices-market-5657 PEGylated Drugs Market Shares Analysis, Key Development Strategies And Forecasts Till 202512/31/2020 PEGylated Drugs Market is expected to register a CAGR of 5.53% to reach USD 13,503.67 Million by 2025.
PEGylation refers to the process of covalent and non-covalent attachment of polyethylene glycol polymer chains to bioactive molecules (proteins, peptides, enzymes, antibody fragments, oligonucleotides, etc.). It is a promising technique to increase the therapeutic efficacy of medicines in clinical settings. Several PEGylated drugs have been approved by the Food and Drug Administration (FDA), and many drugs are being tested in clinical settings. The major companies are rigorously investing in R&D of PEGylated drugs and have a good number of molecules in the pipeline. For instance, UCB and Biogen are evaluating the safety and efficacy of dapirolizumab pegol. Dapirolizumab pegol is an anti-CD40L pegylated Fab and is in Phase 2b of the clinical trial. The drug is being developed for the treatment of systemic lupus erythematosus. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8436 However, adverse reactions associated with PEGylated drugs and drug recalls are anticipated to restrain the growth of the global PEGylated drugs market during the forecast period. Market Dynamics The Global PEGylated Drugs Market is emerging due to the increase in the prevalence of chronic diseases such as cancer, growing pharmaceutical industry, and advancements in the biologics sector. For instance, according to the National Cancer Institute, in 2016, 15.5 million new cases of cancer were registered, and approximately USD 147.3 billion were spent for cancer care in the US. This rising prevalence of cancer is creating a demand for effective drugs. The use of advanced drug delivery system with PEGylation technology is significant in the field of anti-cancer therapy as PEGylating enhances retention time of therapeutics which in turn is expected to boost the growth of the global PEGylated drugs market. Segmentation The Global PEGylated Drugs Market has been segmented into molecule, indication, and region. On the basis of molecule, the global PEGylated drugs market has been segmented into protein, enzyme, aptamer, antigen-binding fragment (FAB’ fragment) and others. PEGylated protein is estimated to account for the largest market share of 64.80% during the forecast period. Rising demand for PEGylation, increase in a number of chronic diseases including cancer, and product launches by major market players are propelling the growth of this segment. For instance, in 2018, Coherus Biosciences has gained FDA approval for its Pegfilgrastim biosimilar, Udenyca (Pegfilgrastim-cbqv). Udenyca is a leukocyte growth factor used to decrease the incidence of infection in patients with non-myeloid malignancies. On the basis of indication, the Global PEGylated Drugs Market has been segregated into cancer, hemophilia, hepatitis, gout, and others. Regional Analysis The Global PEGylated Drugs Market is broadly segmented based on region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas accounted for a market share of 65.73% in 2018. Americas is sub-segmented into North America and South America. North America has been further sub-segmented into the US and Canada. Europe was the second-largest Global PEGylated Drugs Market in 2018. The rising efforts by the government to reduce chronic disease burden owing to the rising occurrence of cancer in the region is projected to drive the market growth. The Europe region is further segmented into Western Europe and Eastern Europe. Western Europe, on the basis of countries has been, segmented into Germany, the UK, France, Italy, Spain, and the rest of Western Europe. The Asia-Pacific region has been categorized as China, India, Japan, Australia, South Korea and the rest of Asia-Pacific. It holds the third-largest position in the PEGylated drugs market. The Middle East & Africa is expected to witness a remarkable growth owing to the increasing applications PEGylated drugs for the treatment of chronic diseases. Prominent Players The Prominent Players in the Global PEGylated Drugs Market Horizon Therapeutics Plc, F. Hoffmann-La Roche Ltd., Pfizer Inc., Novo Nordisk A/S, UCB S.A., Amgen, Inc., AstraZeneca, Merck & Co., Inc., Takeda Pharmaceutical Company Limited, and Bayer AG. The players operating in the global PEGylated Drugs Market are focusing on product launches, along with expanding their global footprints by entering untapped markets. FOR MORE DETAILS – @ https://www.marketresearchfuture.com/reports/pegylated-drugs-market-8436 |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
June 2021
Categories |